Edition:
United States

Avinger Inc (AVGR.OQ)

AVGR.OQ on NASDAQ Stock Exchange Capital Market

1.48USD
4:00pm EDT
Change (% chg)

$0.08 (+5.71%)
Prev Close
$1.40
Open
$1.42
Day's High
$1.49
Day's Low
$1.38
Volume
12,451
Avg. Vol
174,884
52-wk High
$25.16
52-wk Low
$0.95

Chart for

About

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascul... (more)

Overall

Beta: --
Market Cap(Mil.): $7.83
Shares Outstanding(Mil.): 23.91
Dividend: --
Yield (%): --

Financials

  AVGR.OQ Industry Sector
P/E (TTM): -- 148.68 32.76
EPS (TTM): -2.49 -- --
ROI: -918.27 9.38 14.61
ROE: -- 14.71 16.33

BRIEF-Avinger Receives FDA Clearance Of Next Generation Pantheris Device

* AVINGER RECEIVES FDA CLEARANCE OF NEXT GENERATION PANTHERIS DEVICE

May 23 2018

BRIEF-Avinger Q1 Loss Per Share $5.37

* Q1 REVENUE FELL 48 PERCENT TO $1.8 MILLION Source text for Eikon: Further company coverage:

May 14 2018

BRIEF-Avinger Announces First-In-Patient Use Of Extended Nosecone Version Of Next Generation Pantheris

* AVINGER ANNOUNCES FIRST-IN-PATIENT USE OF EXTENDED NOSECONE VERSION OF NEXT GENERATION PANTHERIS Source text for Eikon: Further company coverage:

Mar 29 2018

BRIEF-Avinger To Settle Securities Class Actions For $5 Million

* AVINGER INC - ENTERED INTO BINDING MEMORANDUM OF UNDERSTANDING TO SETTLE SECURITIES CLASS ACTIONS PENDING AGAINST CO, SEVERAL OF OFFICERS & DIRECTORS​

Mar 21 2018

Earnings vs. Estimates